Physician profile
Stephen Hersperger
NPI 1699900217
$1,036.41
in general payments reported to CMS, 2019-2025
8 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2021: $380 · 2022: $237 · 2024: $146 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $380.14 | 2021 | |
| W. L. Gore & Associates, INC. | $145.91 | 2024 | Gore Synecor Biomaterial |
| Davol INC. | $145.19 | 2025 | Phasix Mesh |
| Smith+Nephew, INC. | $117.46 | 2022 | |
| Kci USA, INC. | $102.79 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $101.20 | 2019 | |
| Medical Device Business Services, INC. | $27.27 | 2025 | Vistaseal |
| Atricure, INC. | $16.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Hersperger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.